UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 87,502 Shares of LifeStance Health Group, Inc. (NASDAQ:LFST)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 16.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 604,321 shares of the company's stock after acquiring an additional 87,502 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.16% of LifeStance Health Group worth $4,454,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of LFST. Jennison Associates LLC increased its holdings in LifeStance Health Group by 278.4% in the 4th quarter. Jennison Associates LLC now owns 8,086,380 shares of the company's stock valued at $59,597,000 after acquiring an additional 5,949,438 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of LifeStance Health Group by 87.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock worth $25,977,000 after buying an additional 1,643,390 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of LifeStance Health Group by 7.9% in the 4th quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company's stock worth $78,781,000 after buying an additional 784,818 shares during the last quarter. First Trust Advisors LP bought a new stake in shares of LifeStance Health Group in the 4th quarter worth about $4,535,000. Finally, First Eagle Investment Management LLC increased its holdings in shares of LifeStance Health Group by 182.8% in the 4th quarter. First Eagle Investment Management LLC now owns 785,666 shares of the company's stock worth $5,790,000 after buying an additional 507,826 shares during the last quarter. 85.50% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the business's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the sale, the insider now directly owns 339,810 shares of the company's stock, valued at $2,344,689. The trade was a 5.25% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.20% of the stock is owned by corporate insiders.

LifeStance Health Group Trading Down 1.5%

Shares of LFST stock traded down $0.09 during trading hours on Friday, reaching $5.84. 923,460 shares of the stock were exchanged, compared to its average volume of 1,598,318. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $8.61. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.19. The company's 50-day moving average price is $6.24 and its 200-day moving average price is $7.08. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of -22.46 and a beta of 1.22.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on LFST shares. Canaccord Genuity Group started coverage on shares of LifeStance Health Group in a report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 target price on the stock. KeyCorp started coverage on shares of LifeStance Health Group in a report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 target price on the stock. UBS Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price on the stock in a report on Tuesday, May 27th. Finally, William Blair restated an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $8.50.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.